WARNING: “Buffett Indicator” flashing for first time in 50 years

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

Richard William Scalzo net worth and biography

Richard Scalzo Biography and Net Worth

Insider of Dyne Therapeutics

Richard Scalzo is the VP of Accounting & Admin. and Treasurer at Dyne Therapeutics.

What is Richard William Scalzo's net worth?: The estimated net worth of Richard William Scalzo is at least $3.05 million as of December 11th, 2024. Mr. Scalzo owns 127,078 shares of Dyne Therapeutics stock worth more than $3,048,601 as of December 21st. This net worth evaluation does not reflect any other assets that Mr. Scalzo may own. Learn More about Richard William Scalzo's net worth.
How old is Richard William Scalzo?: Mr. Scalzo is currently 38 years old. There are 7 older executives and no younger executives at Dyne Therapeutics. The oldest executive at Dyne Therapeutics is Dr. Oxana Beskrovnaya Ph.D., Chief Scientific Officer, who is 63 years old. Learn More on Richard William Scalzo's age.
How do I contact Richard William Scalzo?: The corporate mailing address for Mr. Scalzo and other Dyne Therapeutics executives is 1560 Trapelo Road, Waltham, MA 02451, United States. Dyne Therapeutics can also be reached via phone at 781-786-8230 and via email at [email protected]. Learn More on Richard William Scalzo's contact information.
Has Richard William Scalzo been buying or selling shares of Dyne Therapeutics?: During the last ninety days, Richard William Scalzo has sold $40,914.60 in shares of Dyne Therapeutics stock. Most recently, Richard William Scalzo sold 1,455 shares of the business's stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $28.12, for a transaction totalling $40,914.60. Following the completion of the sale, the senior vice president now directly owns 127,078 shares of the company's stock, valued at $3,573,433.36. Learn More on Richard William Scalzo's trading history.
Who are Dyne Therapeutics' active insiders?: Dyne Therapeutics' insider roster includes Oxana Beskrovnaya (Chief Scientific Officer), Joshua Brumm (CEO), John Cox (President & CEO), Wildon Farwell (Insider), Susanna High (COO), Dirk Kersten (Director), and Richard Scalzo (Insider). Learn More on Dyne Therapeutics' active insiders.
Are insiders buying or selling shares of Dyne Therapeutics?: During the last year, Dyne Therapeutics insiders bought shares 2 times. They purchased a total of 1,746,285 shares worth more than $31,057,267.50. During the last year, insiders at the sold shares 48 times. They sold a total of 2,547,573 shares worth more than $62,638,020.82. The most recent insider tranaction occured on December, 11th when insider Oxana Beskrovnaya sold 2,334 shares worth more than $65,632.08. Insiders at Dyne Therapeutics own 20.8% of the company. Learn More about insider trades at Dyne Therapeutics.
Information on this page was last updated on 12/11/2024.

Richard William Scalzo Insider Trading History at Dyne Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/11/2024	Sell	1,455	$28.12	$40,914.60	127,078
9/18/2024	Sell	1,390	$34.55	$48,024.50	98,568
6/10/2024	Sell	1,590	$30.23	$48,065.70	115,105
5/16/2024	Sell	2,588	$28.27	$73,162.76	116,695
3/11/2024	Sell	2,672	$25.28	$67,548.16	119,283
3/7/2024	Sell	2,273	$25.85	$58,757.05	121,955
2/29/2024	Sell	3,429	$27.50	$94,297.50	124,228
1/26/2024	Sell	13,000	$24.34	$316,420.00	124,228
1/3/2024	Sell	13,000	$18.81	$244,530.00	124,228
12/14/2023	Sell	2,376	$12.02	$28,559.52	124,228
12/11/2023	Sell	1,380	$10.72	$14,793.60	126,604
12/6/2023	Sell	1,872	$12.01	$22,482.72	127,984
12/4/2023	Sell	681	$12.01	$8,178.81	129,856
9/18/2023	Sell	1,290	$9.41	$12,138.90	40,795
6/15/2023	Sell	10,000	$12.03	$120,300.00	43,482
3/14/2023	Sell	1,311	$13.33	$17,475.63	54,872
12/12/2022	Sell	312	$10.87	$3,391.44	56,183
3/11/2022	Sell	308	$8.73	$2,688.84
9/20/2021	Sell	367	$15.61	$5,728.87

Richard William Scalzo Buying and Selling Activity at Dyne Therapeutics

Dyne Therapeutics Company Overview

Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $23.99

$23.65

$24.90

50 Day Range

MA: $29.63

$23.99

$35.40

2 Week Range

Now: $23.99

$11.93

$47.45

Volume

1,456,217 shs

Average Volume

1,437,825 shs

Market Capitalization

$2.44 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09

WARNING: “Buffett Indicator” flashing for first time in 50 years

From Behind the Markets | Ad